Stocks to buy in 2025: Blue Jet Healthcare, Havells among 5 stocks that could give 14-49% return
1/6
Brokerage Recommendations
Brokerages remain bullish on select stocks across sectors, highlighting strong fundamentals, growth visibility, and favorable risk-reward profiles for the next 12 months.
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
2/6
Emkay Global on Blue Jet Healthcare
Emkay Global on Blue Jet Healthcare: Buy| Target Rs 1150| LTP Rs 770| Upside 49%
Emkay Global maintains a buy on Blue Jet Healthcare with a target price of Rs 1,150, suggesting a strong upside potential of 49% from the current market price of Rs 770.
Emkay Global maintains a buy on Blue Jet Healthcare with a target price of Rs 1,150, suggesting a strong upside potential of 49% from the current market price of Rs 770.
3/6
Geojit on Havells India
Geojit on Havells India Ltd: Buy| Target Rs 1903| LTP Rs 1598| Upside 19%
Geojit has maintained a ‘Buy’ rating on Havells India Ltd, setting a target price of Rs 1,903, which implies an upside of 19% from the current market price of Rs 1,598
Geojit has maintained a ‘Buy’ rating on Havells India Ltd, setting a target price of Rs 1,903, which implies an upside of 19% from the current market price of Rs 1,598
Amazon Top Deals
POWERED BY
Crompton Ozone 75 Litres Desert Air Cooler for home | Large & Easy Clean Ice Chamber | 4-Way Air Deflection | High Density Honeycomb Pads | Everlast Pump | Auto Fill| 3 Year Brand Warranty
₹9,798Buy Now43%
OFF
LG 32 L Convection Microwave Oven (MC3286BRUM, Black, 360° Motorised Rotisserie for Bar-be-queing, 301 Auto Cook Menu, Stainless steel cavity, Indian Cuisine, Tandoor Se, Steam Clean & Diet Fry)
₹18,780Buy Now22%
OFF
4/6
Axis Securities on Krishna Institute
Axis Securities on Krishna Institute of Medical Sciences: Buy| Target Rs 730| LTP Rs 640| Upside 14%
Axis Securities has maintained a ‘Buy’ rating on Krishna Institute of Medical Sciences (KIMS) with a target price of Rs 730, indicating an upside potential of 14% from the current market price of Rs 640.
Axis Securities has maintained a ‘Buy’ rating on Krishna Institute of Medical Sciences (KIMS) with a target price of Rs 730, indicating an upside potential of 14% from the current market price of Rs 640.
5/6
Elara Capital on SRF
Elara Capital on SRF: Buy| Target Rs 3461| LTP Rs 2881| Upside 20%
Elara Capital has maintained a ‘Buy’ rating on SRF Ltd, assigning a target price of Rs 3,461, which implies a 20% upside from the current market price of Rs 2,881.
Elara Capital has maintained a ‘Buy’ rating on SRF Ltd, assigning a target price of Rs 3,461, which implies a 20% upside from the current market price of Rs 2,881.
6/6
Motilal Oswal on Bharti Airtel
Motilal Oswal on Bharti Airtel: Buy| Target Rs 2110| LTP Rs 1834| Upside 15%
Motilal Oswal has reiterated a ‘Buy’ rating on Bharti Airtel, with a target price of Rs 2,110, suggesting a potential upside of 15% from the current market price of Rs 1,834
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Motilal Oswal has reiterated a ‘Buy’ rating on Bharti Airtel, with a target price of Rs 2,110, suggesting a potential upside of 15% from the current market price of Rs 1,834
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)